company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2637000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2637000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,56000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1273000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1306000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1306000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-980000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,980000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,177000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,177000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,177000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1134000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4205000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4205000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1520000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-231000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2910000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2910000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3675000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3675000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1003000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1003000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8921000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8921000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5008000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3293000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3293000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,103000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,54000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3133000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3120000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-735000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,735000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4927000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,3406000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,97000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8435000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8425000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5297000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 17:21:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,21000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3440000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3440000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,89000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2066000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5414000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5415000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-744000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1237000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,493000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,493000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4921000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,70000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4671000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4671000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2322000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2349000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2349000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1476000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1228000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,141000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-110000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-110000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2622000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,36892000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34269000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34279000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31820000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,70000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4466000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4466000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,304000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10637000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5267000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5267000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-83000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-30994000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2214000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3681000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29610000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29610000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9987000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19815000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29792000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29792000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5085000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,196000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9152000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9152000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,566000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3137000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2772000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8211000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8211000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12951000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1843000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1476000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13385000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13385000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18173000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1803000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-15010000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,92224000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,45000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57283000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57283000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-28000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35659000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 16:27:17+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,386000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,617000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1939000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1021000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7733000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7733000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-179000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-281000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,741000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,281000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,281000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,106000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1002000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-156000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1052000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1052000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,32000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8472000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,27000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10130000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10130000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,701000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1524000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1079000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6816000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6816000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-388000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49405000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49405000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-415000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44996000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,152000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44733000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44733000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11485000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,171000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10256000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10256000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,159000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2221000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1564000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9428000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9428000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,163000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-311249000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,274470000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37616000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37616000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-14000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,67000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-46963000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,358000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8774000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8774000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,520000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,392000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1154000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9006000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9006000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-193000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,225500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32451000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32451000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-3000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-104000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20341000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:43:01+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,206000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,536000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1151000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-212000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8800000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8800000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1049000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-712000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,704205000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8844000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8844000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17573000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,209000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,540000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,45498000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1904000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10298000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10298000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-758000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-687747000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,699500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10995000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10995000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,264000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,264000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,264000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-31000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,930000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,213000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12855000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12855000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,244000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,99000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1953000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,168000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10391000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10391000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-389000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-457847000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,457647000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-589000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-589000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-189000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,24779000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24584000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24584000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13584000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,429000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18067000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18067000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,244000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,120000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2253000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2041000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13409000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13409000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-196399000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,196847000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,442000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,26000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12941000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:33:24+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,721000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,21196000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21196000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,249000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,119000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13528000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1604000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,36696000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,36696000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30947000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,89199000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,58239000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,58239000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94945000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,726000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13371000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13371000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,245000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,119000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2092000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7124000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18039000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18039000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1494000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,747000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1753000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1753000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-262000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12125000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11863000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11863000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,17000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7912000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,732000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23333000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,253000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,120000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10457000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4068000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16571000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16571000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1090000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1494000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,357000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,357000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,169000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2599000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2768000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2768000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-52000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13498000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,732000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12612000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,392000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,119000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1814000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8149000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18436000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18436000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-494000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,996000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2498000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2498000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-67000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1223000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1151000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1151000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19783000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 08:02:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,733000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10380000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10380000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,213000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,118000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1844000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3281000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11486000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11486000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1494000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,494000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1011000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1011000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2332000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26239000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,146000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23775000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23775000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11278000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,766000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8920000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8920000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,323000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,132000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2193000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2334000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8606000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8606000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-996000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,996000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1378000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1372000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1372000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9983000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,738000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15598000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,234000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,143000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9426000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6138000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,343000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,343000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,15000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-747000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1494000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2238000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2238000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-165000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-27463000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27545000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-83000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-83000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1978000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,729000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8548000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8548000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,249000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,140000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1384000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6439000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13214000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13214000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-498000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,747000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,249000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,249000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3000000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-57000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15614000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12520000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12520000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-445000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 08:02:18+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,728000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6373000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6373000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,247000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,139000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1592000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1793000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6188000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6188000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-744000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,498000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-246000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-246000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-86000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3896000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-687000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-687000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7121000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,681000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8833000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,247000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,139000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2077000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15662000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4366000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4366000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1736000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,744000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-992000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-992000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4500000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-21000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4884000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-9000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,354000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,354000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5004000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,602000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8634000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8634000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,247000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,600000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2310000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17984000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12507000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12507000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1240000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1736000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,496000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,496000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25843000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-7000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-24394000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24384000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-25860000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-25860000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12857000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1954000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6787000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6787000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,261000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2306000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1271000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5491000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5491000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-496000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1240000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,744000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,744000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-123000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-123000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-123000.0
Aratana Therapeutics Inc,PETX,54930060AUDONOJ9U804,0001509190,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 08:02:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4870000.0
